Hemophagocytic lymphohistiocytosis (HLH) is a rare disease that usually occurs in infants and young children. It may also occur in adults. Children usually inherit the disease.
In adults, many different conditions, including infections and cancer, can cause HLH. Hemophagocytic lymphohistiocytosis (HLH) is an aggressive and life-threatening syndrome of excessive immune activation. HLH most often affects infants from birth to 18 months of age, but it also occurs in children and adults of all ages. Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of overwhelming inflammation (hyperinflammation) that causes multiorgan failure and death, making prompt and appropriate...
hlh medical acronym, In hematology, hemophagocytic lymphohistiocytosis (HLH), also known as haemophagocytic lymphohistiocytosis (British spelling), and hemophagocytic or haemophagocytic syndrome, [1] is an uncommon hematologic disorder seen more often in children than in adults. Hemophagocytic lymphohistiocytosis (HLH) is a condition that occurs when your immune system abnormally overreacts. Your immune system defends your body from things that make you sick, like bacteria and viruses. Cells, proteins, organs and tissues work together to keep you healthy. Traditionally, HLH has been treated with the HLH-2004 protocol involving dexamethasone and etoposide.
hlh medical acronym, These therapies were designed for children with congenital HLH due to deficiencies in natural killer cell function. Hemophagocytic lymphohistiocytosis (HLH) is rare life-threatening syndrome that can affect infants, children, adolescents and adults. HLH is not a single disease, however; it is a group of disorders of the immune system that can be triggered by infections, cancer or rheumatologic diseases. There are two types of HLH. “Primary,” or “familial,” HLH is caused by an inherited problem of the immune system. “Secondary” HLH can occur when the immune system is disturbed (for example, by infections), but not necessarily because of an inherited condition.
